Emrelis is the first FDA-approved treatment for previously treated patients with locally advanced or metastatic non-squamous ...

Welireg marks the first FDA-approved non-surgical treatment option for locally advanced, unresectable, or metastatic ...

Polanco, executive VP and chief commercial officer, Novartis US, and the 2025 Healthcare Businesswomen’s Association Woman of ...

The decision follows ongoing investigations into serious adverse events primarily reported in elderly individuals who ...

Under the agreement, GSK will acquire BP Asset IX, a subsidiary of Boston Pharmaceuticals, for up to $2 billion in total cash ...

Leandro Boer, MD, PhD, VP, US general medicines, Amgen, discusses new real-world data showing that most high-risk ...

Weight-loss and diabetes drugs dominated pharmaceutical spending last year, according to a new report by the American Society ...

What was once considered a competitive advantage for forward-thinking commercial teams has now become essential for success ...

The order pushes drug companies to reduce drug prices in the United States to fall in line with other countries around the ...

The latest Q&A installment in Pharm Exec's earned media series details key strategies for leveraging breaking news at ...

Stricter regulations on a fragmented media landscape is forcing the industry to rethink marketing.

The 700,000 square-foot facility is expected to create 400 high-wage manufacturing jobs once operational.